Cerecor Inc. CERC
2.93 +2.93
Day range unavailable
52-week range unavailable
News
globenewswire.com Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc. WAYNE, Pa. and ROCKVILLE, Md., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a leading clinical-stage precision medicine company that discovers, develops, and…
globenewswire.com Cerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates ROCKVILLE, Md. and CHESTERBROOK, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization…
globenewswire.com Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance Achieved performance milestone with positive initial results from its Phase 1b trial of CERC-002 in moderate-to- severe Crohn's Disease who had previously failed three or more lines of biologics…
benzinga.com 44 Stocks Moving In Tuesday's Mid-Day Session Gainers
benzinga.com Cerecor's Crohn's Disease Candidate Shows Encouraging Response In Pretreated Patients Cerecor Inc (NASDAQ: CERC) announced initial results from a Phase 1b proof-of-concept study evaluating CERC-002 in adult patients with moderate to severe Crohn's disease (CD). CERC-002 is an…
globenewswire.com Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets Cerecor completes divestiture of non-core neurology pipeline assets as it increases its focus on immunology, immuno-oncology, and rare genetic disorders Cerecor completes divestiture of non-core…
benzinga.com 50 Biggest Movers From Yesterday Gainers MoSys, Inc. (NASDAQ: MOSY) shares jumped 44.1% to settle at $5.46 on Wednesday. Lianluo Smart Limited (NASDAQ: LLIT) gained 24.6% to settle at $9.22.
benzinga.com 35 Stocks Moving In Wednesday's Mid-Day Session Gainers Advaxis, Inc. (NASDAQ: ADXS) shares jumped 43.1% to $0.6943 after jumping over 14% on Tuesday. MoSys, Inc. (NASDAQ: MOSY) shares gained 32% to $5.00.
pennystocks.com Top Penny Stocks to Buy Moving in Premarket? Check These 3 Out These 3 penny stocks made big moves in pre-market trading; are they worth it? The post Top Penny Stocks to Buy Moving in Premarket?
benzinga.com Cerecor Shares Gain After FDA Fast Track Review Tag For CERC-002 In Hospitalized COVID-19 Patients The FDA has granted Fast Track designation to Cerecor Inc's (NASDAQ: CERC) CERC-002 to treat hospitalized patients with COVID-19. CERC-002 is a first-in-class fully human monoclonal antibody…
marketwatch.com Cerecor's investigational COVID-19 therapy gets Fast Track designation from the FDA Shares of Cerecor Inc. gained 17.3% in premarket trading on Tuesday after the company said its experimental COVID-19 drug had received a Fast Track designation from the Food and Drug Administration.…
investorplace.com A Small Biotech Stock That Has All The Right Ingredients for a Big 2021 Breakout $230 million biopharmaceutical company Cerecor (CERC) may end up being the industry's biggest winner on Wall Street over the next six months. The post A Small Biotech Stock That Has All The Right…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021 
benzinga.com Cerecor Inks New Global License Agreement With Kyowa Kirin For CERC-002 Cerecor Inc's (NASDAQ: CERC) wholly-owned subsidiary, Aevi Genomic Medicine LLC, has entered into an expanded agreement with Kyowa Kirin Co Ltd (OTCMKTS: KYKOF) for exclusive worldwide rights to…
globenewswire.com Cerecor Reports 2020 Financial Results and Provides Business Updates ROCKVILLE, Md. and CHESTERBROOK, Pa., March 08, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of…
globenewswire.com Cerecor to Present at Upcoming Investor Conferences ROCKVILLE, Md. and CHESTERBROOK, Pa., March 04, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization…
pulse2.com CERC Stock Price Increases Over 10% Pre-Market: Why It Happened The stock price of Cerecor Inc. (NASDAQ:CERC) is trading at over 10% pre-market. This is why it happened.
benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning trading, 285 companies set new 52-week highs.
globenewswire.com Cerecor Announces Fast Track Designation for CERC-803 for the Treatment of Leukocyte Adhesion Deficiency Type II ROCKVILLE, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and…
globenewswire.com Cerecor Announces Proceeds from Option to Purchase Additional Shares of Common Stock Bringing Public Offering Proceeds to $40.7 Million ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (“Cerecor”; NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and…
globenewswire.com Cerecor Inc. Announces Closing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of…
globenewswire.com Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of…
globenewswire.com Cerecor Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of…
globenewswire.com Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still's Disease ROCKVILLE, Md. and CHESTERBROOK, Pa., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of…
globenewswire.com Cerecor Announces First Patient Dosed in a Phase 1b Clinical Trial of CERC-007 for the Treatment of Relapsed or Refractory Multiple Myeloma Initial data anticipated in the first quarter of 2021 Initial data anticipated in the first quarter of 2021
benzinga.com 90 Biggest Movers From Yesterday Gainers
benzinga.com Stocks That Hit 52-Week Lows On Monday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com Stocks That Hit 52-Week Lows On Friday
- benzinga.com 64 Biggest Movers From Yesterday
- benzinga.com 22 Stocks Moving In Monday's Pre-Market Session
- benzinga.com 38 Biggest Movers From Yesterday
- benzinga.com 40 Biggest Movers From Yesterday
- benzinga.com 35 Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com 45 Biggest Movers From Yesterday
- benzinga.com Mid-Day Market Update: Hain Celestial Drops Following Announcement of Delay in Earnings Release; Sito Mobile Shares Surge